Trial
NCT01080638
Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction.
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Seoul National University Hospital
Collaborators
Seoul National University Bundang Hospital
Condition
Myocardial Infarction
Intervention
glycoprotein IIb/IIIa inhibitor (abciximab)
Why stopped
The study was terminated early due to a shortage of research and analytical personnel, which prevented the completion of the study as planned
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-27